All filters
Slidesets
Clinical Case Discussion - Ignacio Pérez-Valero, MD, PhD
Presented at:
Spanish HIV Clinical Forum 2016
Slidesets
Designing Clinical Trials: Highlights & Tips - Andrew Hill, MD
Presented at:
Spanish HIV Clinical Forum 2016
Slidesets
Analyzing Clinical Datasets: Challenges & Pitfalls - Julia Del Amo, MD, PhD
Presented at:
Spanish HIV Clinical Forum 2016
Slidesets
Virological Approach - Small interfering RNA’s | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
Presented at:
International Workshop on HBV Cure 2016
Slidesets
Virological Approach - New Nucleoside Analogue & Capsid inhibition | Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2016
Slidesets
Virological Approach - Assembly and Secretion Inhibitors | Tim Block, PhD
Presented at:
International Workshop on HBV Cure 2016
Slidesets
Virological Approach - CCC – DNA inhibition | Massimo Levrero, MD
Presented at:
International Workshop on HBV Cure 2016
Slidesets
Immunomodulatory Agents - Therapeutic Vaccines | Kyong-Mi Chang, MD
Presented at:
International Workshop on HBV Cure 2016
Slidesets
How does HBV interact with the immune system? | Robert Thimme, MD
Presented at:
International Workshop on HBV Cure 2016
Slidesets
Adaptive Immunity: - PDL Blockers | Mala Maini, MD, PhD
Presented at:
International Workshop on HBV Cure 2016
Slidesets
How to combine new treatments? Clinical approach | Marion Peters, MD
Presented at:
International Workshop on HBV Cure 2016
Slidesets
Current Status of HBV Therapy | Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2016
Slidesets
Why do we need new treatments and what is our definition of cure? | Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2016
Slidesets
How to combine new treatments? Scientific approach | Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2016
Slidesets
Virological Approach - Entry inhibition | Stephan Urban, PhD
Presented at:
International Workshop on HBV Cure 2016
Slidesets
Can Bariatric surgery convert a non-candidate to a candidate? - Julie Heimbachx, MD
Presented at:
Symposium on Key Issues in Liver Transplantation for NASH 2016
Slidesets
What is an acceptable BMI - Lee Kaplan, MD, PhD
Presented at:
Symposium on Key Issues in Liver Transplantation for NASH 2016
Slidesets
How should we optimize immunosuppression? - Kittie Wynne, MD, PhD
Presented at:
Symposium on Key Issues in Liver Transplantation for NASH 2016
Slidesets
Rifampin vs. Rifapentine: a debate over the preferred rifamycin | Kelly Dooley, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Slidesets
Pharmacokinetic Modeling and Simulation of the Interaction between Moxifloxacin and Rifapentine in Healthy Volunteers | M. Imperial
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016